BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 31395058)

  • 1. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.
    Räsänen M; Renkonen-Sinisalo L; Mustonen H; Lepistö A
    World J Surg Oncol; 2019 Aug; 17(1):139. PubMed ID: 31395058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers.
    Delaney CP; Lavery IC; Brenner A; Hammel J; Senagore AJ; Noone RB; Fazio VW
    Ann Surg; 2002 Aug; 236(2):203-7. PubMed ID: 12170025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.
    Ferrigno R; Novaes PE; Silva ML; Nishimoto IN; Nakagawa WT; Rossi BM; Ferreira Fde O; Lopes A
    Radiat Oncol; 2006 Mar; 1():5. PubMed ID: 16722598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiological lymph-node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes.
    Peng S; Liu X; Li Y; Yu H; Xie Y; Wang X; Zhou J; Zhu M; Luo Y; Huang M
    Cancer Med; 2023 May; 12(9):10303-10314. PubMed ID: 36938675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is radiotherapy necessary for upper rectal cancer underwent curative resection? A retrospective study of 363 patients.
    Ma Z; Zhou J; Liu K; Chen S; Wu Q; Peng L; Zhao W; Zhu S
    Radiat Oncol; 2024 Jan; 19(1):8. PubMed ID: 38238776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the anorectal function before and after neoadjuvant radiotherapy in mid-low rectal cancer: a retrospective observational study from single center].
    Sun Z; Wang ZF; Sun XY; Xu L; Zhang GN; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan; 27(1):63-68. PubMed ID: 38262902
    [No Abstract]   [Full Text] [Related]  

  • 7. Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment.
    François E; Magné N; Boulahssass R; Ronchin P; Huguenet V; De Lavigerie B; Nouhaud E; Cattenoz C; Martel-Lafay I; Terret C; Artru P; Clavere P; Tchalla A; Vendrely V; Duc S; Boige V; De Sousa Carvalho N; Gal J; De Bari B
    Radiother Oncol; 2024 Apr; 193():110144. PubMed ID: 38341097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the optimal timing of surgery after short-course radiotherapy for rectal cancer?
    Donnelly SM; Wyatt J; Powell SG; Jones N; Altaf K; Ahmed S
    Surg Oncol; 2023 Dec; 51():101992. PubMed ID: 37757518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy.
    Gash KJ; Chambers AC; Cotton DE; Williams AC; Thomas MG
    Br J Cancer; 2017 Jul; 117(2):210-219. PubMed ID: 28641310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors.
    Skóra T; Nowak-Sadzikowska J; Martynów D; Wszołek M; Sas-Korczyńska B
    J Radiat Oncol; 2018; 7(1):77-84. PubMed ID: 29576860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service.
    Morris EJA; Finan PJ; Spencer K; Geh I; Crellin A; Quirke P; Thomas JD; Lawton S; Adams R; Sebag-Montefiore D
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):522-531. PubMed ID: 26936609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinoma.
    Chen CH; Hsieh MC; Hsiao PK; Lin EK; Lu YJ; Wu SY
    J Cancer; 2017; 8(10):1927-1934. PubMed ID: 28819391
    [No Abstract]   [Full Text] [Related]  

  • 13. IFN-Type-I Response and Systemic Immunity in Rectal Adenocarcinoma Patients Treated with Conventional or Hypofractionated Neoadjuvant Radiotherapy.
    Koukourakis IM; Xanthopoulou E; Koukourakis MI; Tiniakos D; Kouloulias V; Zygogianni A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced changes in gene expression in rectal cancer specimens.
    Hillson LVS; McCulloch AK; Edwards J; Dunne PD; O'Cathail SM; Roxburgh CS
    Clin Transl Oncol; 2024 Jun; 26(6):1419-1428. PubMed ID: 38243085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pelvic radiotherapy strategy for rectal cancer with hepatic metastasis].
    Wang L; Li MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):295-299. PubMed ID: 38532594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological Outcomes.
    Hazen SJA; Sluckin TC; Intven MPW; Beets GL; Beets-Tan RGH; Borstlap WAA; Buffart TE; Buijsen J; Burger JWA; van Dieren S; Furnée EJB; Geijsen ED; Hompes R; Horsthuis K; Leijtens JWA; Maas M; Melenhorst J; Nederend J; Peeters KCMJ; Rozema T; Tuynman JB; Verhoef C; de Vries M; van Westreenen HL; de Wilt JHW; Zimmerman DDE; Marijnen CAM; Tanis PJ; Kusters M;
    JAMA Oncol; 2024 Feb; 10(2):202-211. PubMed ID: 38127337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining preoperative treatment strategies in t3 rectal cancer.
    Bosset JF; Bosset M; Nguyen F; Servagi-Vernat S; Sedrati A
    Gastrointest Cancer Res; 2008 Jul; 2(4 Suppl):S54-7. PubMed ID: 19343151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local recurrence during and after short-term irradiation followed by chemotherapy and TME: 5-year follow-up of the RAPIDO study].
    Germer CT; Reibetanz J
    Chirurgie (Heidelb); 2023 Jul; 94(7):642-643. PubMed ID: 37347289
    [No Abstract]   [Full Text] [Related]  

  • 19. Repopulation of Rectal Cancer May Explain Worse Local Control After Short-Course Radiation Therapy in the RAPIDO Trial.
    Socha J; Bujko K
    Dis Colon Rectum; 2024 Mar; 67(3):e204-e205. PubMed ID: 38064232
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002).
    Wang J; Guan Y; Gu W; Yan S; Zhou J; Huang D; Tong T; Li C; Cai S; Zhang Z; Zhu J
    Radiat Oncol; 2019 Nov; 14(1):215. PubMed ID: 31783766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.